Clinical Trial: EDAS Revascularization for Symptomatic Intracranial Atherosclerotic Steno-occlusive Disease, Phase IIb

U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07864649) titled 'EDAS Revascularization for Symptomatic Intracranial Atherosclerotic Steno-occlusive Disease, Phase IIb' on Oct. 02.

Brief Summary: ERSIAS IIb is a multicenter randomized controlled trial, with a Phase IIb design, to find out whether encephaloduroarteriosynangiosis (EDAS), a type of indirect surgical revascularization of the brain, added to intensive medical management, lowers the rate of recurrent stroke and death compared with intensive medical management alone. The trial enrolls 170 adults who have had a recent ischemic stroke or transient ischemic attack caused by intracranial atherosclerotic disease, with a narrowing or blockage ...